Market Access, Regulatory and Clinical Trial Experts in Europe
Pharma Design is a small service provider with a network of specialised consultants.
Core Services
- Strategic and Regulatory advice
- Marketing Applications, Scientific Advice, Paediatric Advice
- Orphan Designation
- Paediatric Plan and PDCO interaction
- Clinical Trial Design and CTA submission (EU, UK, Switzerland, Israel)
- Clinical Safety & Pharmacovigilance (DSUR, PSUR, RMP submission)
- Establishment of European subsidiaries, legal entities, headquarters, management teams
Our Services Are Highly Competitive
Pharmacovigilance
Our PV services covering your products in Europe, including EU, UK, Switzerland.
Regulatory Consulting
Choose our Regulatory Affairs strategic services for your products or have our specialised consultants outsourced to your team.
Market Access
Let us help you establish legal entity in Europe and prepare for Market Launch.
Recent Articles
-
UK Clinical Trials Revamp: MHRA Launches Route B for Low-Risk Amendments
Key summary: The Medicines and Healthcare products Regulatory Agency (MHRA) has launched a pivotal pilot program today, October 1, 2025, as part of the rollout…
-
Reflection Paper on a Tailored Clinical Approach in Biosimilar Development out for consultation
Document Overview The Reflection Paper on a Tailored Clinical Approach in Biosimilar Development (EMA/CHMP/BMWP/60916/2025), published by the European Medicines Agency (EMA) on March 17,…
News and Updates
-
EMA meets industry stakeholders on scientific advice and clinical trial coordination
On 3rd July 2025 EMA conducted its annual meeting with representatives of industry stakeholders to address topics of evidence generation along the medicine’s life…